CLC Number:
1 |
Dale HH . On some physiological actions of ergot[J]. J Physiol, 1906, 34 (3): 163- 206.
doi: 10.1113/jphysiol.1906.sp001148 |
2 |
Ahlquist RP . A study of the adrenotropic receptors[J]. Am J Physiol, 1948, 153 (3): 586- 600.
doi: 10.1152/ajplegacy.1948.153.3.586 |
3 |
Lands AM , Luduena FP , Buzzo HJ . Differentiation of receptors responsive to isoproterenol[J]. Life Sci, 1967, 6 (21): 2241- 2249.
doi: 10.1016/0024-3205(67)90031-8 |
4 |
Langer SZ . Presynaptic regulation of catecholamine release[J]. Biochem Pharmacol, 1974, 23 (13): 1793- 1800.
doi: 10.1016/0006-2952(74)90187-7 |
5 | Han C , Abel PW , Minneman KP . Heterogeneity of alpha 1-adrenergic receptors revealed by chlorethylclonidine[J]. Mol Pharmacol, 1987, 32 (4): 505- 510. |
6 | James B . Pioneers in cardiology: Sir James Black, MB, ChB, FRS, FRCP. Interview by Mark Nicholls[J]. Circulation, 2008, 117 (8): f47- f48. |
7 |
Cerione RA , Strulovici B , Benovic JL , et al. Pure beta-adrenergic receptor: The single polypeptide confers catecholamine responsiveness to adenylate cyclase[J]. Nature, 1983, 306 (5943): 562- 566.
doi: 10.1038/306562a0 |
8 |
Nguyen AH , Thomsen A , Cahill TR , et al. Structure of an endosomal signaling GPCR-G protein-beta-arrestin megacomplex[J]. Nat Struct Mol Biol, 2019, 26 (12): 1123- 1131.
doi: 10.1038/s41594-019-0330-y |
9 |
Page IH , Helmer OM . A crystalline pressor substance (angiotonin) resulting from the reaction between renin and renin-activator[J]. J Exp Med, 1940, 71 (1): 29- 42.
doi: 10.1084/jem.71.1.29 |
10 |
Lin SY , Goodfriend TL . Angiotensin receptors[J]. Am J Physiol, 1970, 218 (5): 1319- 1328.
doi: 10.1152/ajplegacy.1970.218.5.1319 |
11 |
Whitebread S , Mele M , Kamber B , et al. Preliminary biochemical characterization of two angiotensin Ⅱ receptor subtypes[J]. Biochem Biophys Res Commun, 1989, 163 (1): 284- 291.
doi: 10.1016/0006-291X(89)92133-5 |
12 |
Xiao RP , Zhang SJ , Chakir K , et al. Enhanced G(i) signaling selectively negates beta2-adrenergic receptor (AR), but not beta1-AR-mediated positive inotropic effect in myocytes from failing rat hearts[J]. Circulation, 2003, 108 (13): 1633- 1639.
doi: 10.1161/01.CIR.0000087595.17277.73 |
13 |
Noma T , Lemaire A , Naga PS , et al. Beta-arrestin-mediated beta1-adrenergic receptor transactivation of the EGFR confers cardioprotection[J]. J Clin Invest, 2007, 117 (9): 2445- 2458.
doi: 10.1172/JCI31901 |
14 |
Li Y , Zhang H , Liao W , et al. Transactivated EGFR mediates α1-AR-induced STAT3 activation and cardiac hypertrophy[J]. Am J Physiol Heart Circ Physiol, 2011, 301 (5): H1941- H1951.
doi: 10.1152/ajpheart.00338.2011 |
15 |
Liu F , He K , Yang X , et al. α1A-adrenergic receptor induces activation of extracellular signal-regulated kinase 1/2 through endocytic pathway[J]. PLoS One, 2011, 6 (6): e21520.
doi: 10.1371/journal.pone.0021520 |
16 |
Wang W , Bian J , Li Z . Internalized activation of membrane receptors: From phenomenon to theory[J]. Trends Cell Biol, 2021, 31 (6): 428- 431.
doi: 10.1016/j.tcb.2021.03.008 |
17 |
Wang W , Qiao Y , Li Z . New insights into modes of GPCR activation[J]. Trends Pharmacol Sci, 2018, 39 (4): 367- 386.
doi: 10.1016/j.tips.2018.01.001 |
18 | Liang N , Bing Z , Wang Y , et al. Clinical implications of EGFR-associated MAPK/ERK pathway in multiple primary lung cancer[J]. Clin Transl Med, 2022, 12 (5): e847. |
19 |
Zaryouh H , De Pauw I , Baysal H , et al. Recent insights in the PI3K/Akt pathway as a promising therapeutic target in combination with EGFR-targeting agents to treat head and neck squamous cell carcinoma[J]. Med Res Rev, 2022, 42 (1): 112- 155.
doi: 10.1002/med.21806 |
20 |
Andl CD , Mizushima T , Oyama K , et al. EGFR-induced cell migration is mediated predominantly by the JAK-STAT pathway in primary esopha-geal keratinocytes[J]. Am J Physiol Gastrointest Liver Physiol, 2004, 287 (6): G1227- G1237.
doi: 10.1152/ajpgi.00253.2004 |
21 |
Wang J , Ma J , Nie H , et al. Hepatic regulator of G protein signaling 5 ameliorates nonalcoholic fatty liver disease by suppressing transforming growth factor beta-activated kinase 1-c-Jun-N-terminal kinase/p38 signaling[J]. Hepatology, 2021, 73 (1): 104- 125.
doi: 10.1002/hep.31242 |
22 |
Grimm M , Brown JH . Beta-adrenergic receptor signaling in the heart: Role of CaMKⅡ[J]. J Mol Cell Cardiol, 2010, 48 (2): 322- 330.
doi: 10.1016/j.yjmcc.2009.10.016 |
23 |
Xiao H , Li H , Wang JJ , et al. IL-18 cleavage triggers cardiac inflammation and fibrosis upon β-adrenergic insult[J]. Eur Heart J, 2018, 39 (1): 60- 69.
doi: 10.1093/eurheartj/ehx261 |
24 | 尹峰, 吕志珍, 韩启德, 等. β2-肾上腺素受体在新生大鼠心肌成纤维细胞中的分布及其促增殖作用[J]. 生理学报, 2003, 55 (3): 251- 254. |
25 |
Schnee JM , Hsueh WA . Angiotensin Ⅱ, adhesion, and cardiac fibrosis[J]. Cardiovasc Res, 2000, 46 (2): 264- 268.
doi: 10.1016/S0008-6363(00)00044-4 |
26 |
Xiao H , Ma X , Feng W , et al. Metformin attenuates cardiac fibrosis by inhibiting the TGFβ1-Smad3 signalling pathway[J]. Cardiovasc Res, 2010, 87 (3): 504- 513.
doi: 10.1093/cvr/cvq066 |
27 | Lim GB . Sustained BP reduction with renal denervation[J]. Nat Rev Cardiol, 2022, 19 (6): 352. |
28 |
Ruiz-Ortega M , Lorenzo O , Rupérez M , et al. Angiotensin Ⅱactivates nuclear transcription factor κB through AT1 and AT2 in vascular smooth muscle cells: molecular mechanisms[J]. Circ Res, 2000, 86 (12): 1266- 1272.
doi: 10.1161/01.RES.86.12.1266 |
29 |
Verweij P , Danaietash P , Flamion B , et al. Randomized dose-response study of the new dual endothelin receptor antagonist aprocitentan in hypertension[J]. Hypertension, 2020, 75 (4): 956- 965.
doi: 10.1161/HYPERTENSIONAHA.119.14504 |
30 |
Kong P , Cui ZY , Huang XF , et al. Inflammation and atherosclerosis: Signaling pathways and therapeutic intervention[J]. Signal Transduct Target Ther, 2022, 7 (1): 131.
doi: 10.1038/s41392-022-00955-7 |
31 |
Robbins CS , Chudnovskiy A , Rauch PJ , et al. Extramedullary hematopoiesis generates Ly-6Chigh monocytes that infiltrate atherosclerotic lesions[J]. Circulation, 2012, 125 (2): 364- 374.
doi: 10.1161/CIRCULATIONAHA.111.061986 |
32 |
Hinterdobler J , Schott S , Jin H , et al. Acute mental stress drives vascular inflammation and promotes plaque destabilization in mouse atherosclerosis[J]. Eur Heart J, 2021, 42 (39): 4077- 4088.
doi: 10.1093/eurheartj/ehab371 |
33 |
Han C , Liu J , Liu X , et al. Angiotensin Ⅱ induces C-reactive protein expression through ERK1/2 and JNK signaling in human aortic endothelial cells[J]. Atherosclerosis, 2010, 212 (1): 206- 212.
doi: 10.1016/j.atherosclerosis.2010.05.020 |
34 |
Li M , Liu J , Han C , et al. Angiotensin Ⅱ induces the expression of C-reactive protein via MAPK-dependent signal pathway in U937 macrophages[J]. Cell Physiol Biochem, 2011, 27 (1): 63- 70.
doi: 10.1159/000325206 |
35 |
Xu L , Liu JT , Li K , et al. Genistein inhibits Ang Ⅱ-induced CRP and MMP-9 generations via the ER-p38/ERK1/2-PPARγ-NF-κB signaling pathway in rat vascular smooth muscle cells[J]. Life Sci, 2019, 216, 140- 146.
doi: 10.1016/j.lfs.2018.11.036 |
36 |
Ridker PM , Rane M . Interleukin-6 signaling and anti-interleukin-6 therapeutics in cardiovascular disease[J]. Circ Res, 2021, 128 (11): 1728- 1746.
doi: 10.1161/CIRCRESAHA.121.319077 |
37 |
Geraghty L , Santangeli P , Tedrow UB , et al. Contemporary management of electrical storm[J]. Heart Lung Circ, 2019, 28 (1): 123- 133.
doi: 10.1016/j.hlc.2018.10.005 |
[1] | Yuanmei LIU, Yicheng FU, Jingxin HAO, Fuchun ZHANG, Huilin LIU. Construction and validation of a nomogram for predicting in-hospital postoperative heart failure in elderly patients with hip fracture [J]. Journal of Peking University (Health Sciences), 2024, 56(5): 874-883. |
[2] | Ying WEI,Ming CUI,Shuwang LIU,Haiyi YU,Wei GAO,Lei LI. Different levels and clinical significance of growth differentiation factor-15 in patients with atrial fibrillation [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 715-721. |
[3] | Jing HE,Zhongze FANG,Ying YANG,Jing LIU,Wenyao MA,Yong HUO,Wei GAO,Yangfeng WU,Gaoqiang XIE. Relationship between lipid metabolism molecules in plasma and carotid atheroscle-rotic plaques, traditional cardiovascular risk factors, and dietary factors [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 722-728. |
[4] | Tianjing ZHOU,Qiuping LIU,Minglu ZHANG,Xiaofei LIU,Jiali KANG,Peng SHEN,Hongbo LIN,Xun TANG,Pei GAO. Comparison of initiation of antihypertensive therapy strategies for primary prevention of cardiovascular diseases in Chinese population: A decision-analytic Markov modelling study [J]. Journal of Peking University (Health Sciences), 2024, 56(3): 441-447. |
[5] | Shengjia PENG,Yu QI,Lijie SUN,Dan LI,Xinyu WANG,Jiangli HAN,Baoxia CHEN,Yuan ZHANG. Afferent baroreflex failure with hyponatremia: A case report [J]. Journal of Peking University (Health Sciences), 2024, 56(2): 357-361. |
[6] | Fangfang WANG,Fumeng LIANG,Nan LI,Xiaoxiao WANG,Jiangli HAN,Lijun GUO. Index of microcirculatory resistance is associated with left ventricular remodeling in patients with acute anterior ST-segment elevation myocardial infarction undergoing emergency primary percutaneous coronary intervention [J]. Journal of Peking University (Health Sciences), 2024, 56(1): 150-156. |
[7] | Ying LIU,Ran HUO,Hui-min XU,Zheng WANG,Tao WANG,Hui-shu YUAN. Correlations between plaque characteristics and cerebral blood flow in patients with moderate to severe carotid stenosis using magnetic resonance vessel wall imaging [J]. Journal of Peking University (Health Sciences), 2023, 55(4): 646-651. |
[8] | Ming-lu ZHANG,Qiu-ping LIU,Chao GONG,Jia-min WANG,Tian-jing ZHOU,Xiao-fei LIU,Peng SHEN,Hong-bo LIN,Xun TANG,Pei GAO. Comparison of aspirin treatment strategies for primary prevention of cardiovascular diseases: A decision-analytic Markov modelling study [J]. Journal of Peking University (Health Sciences), 2023, 55(3): 480-487. |
[9] | Zhe LIANG,Fang-fang FAN,Yan ZHANG,Xian-hui QIN,Jian-ping LI,Yong HUO. Rate and characteristics of H-type hypertension in Chinese hypertensive population and comparison with American population [J]. Journal of Peking University (Health Sciences), 2022, 54(5): 1028-1037. |
[10] | Hai-ying XING,Yu-hui CHEN,Ke XU,Dian-dian HUANG,Qing PENG,Ran LIU,Wei SUN,Yi-ning HUANG. Evaluation of carotid atherosclerotic plaques by vascular plaque quantification (VPQ) technology of three-dimensional ultrasonography [J]. Journal of Peking University (Health Sciences), 2022, 54(5): 991-999. |
[11] | XU Hao,ZHANG Guo-dong,FAN Guang-pu,CHEN Yu. Preoperative plasma predictive factors of new-onset atrial fibrillation after coronary artery bypass graft surgery: A propensity score matching study [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1139-1143. |
[12] | ZHUANG Jin-man,LI Tian-run,LI Xuan,LUAN Jing-yuan,WANG Chang-ming,FENG Qi-chen,HAN Jin-tao. Application of Rotarex mechanical thrombectomy system in acute lower limb ische-mia [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1159-1162. |
[13] | Shao-min CHEN,Chao SUN,Xin-yu WANG,Yuan ZHANG,Shu-wang LIU. Arrhythmogenic right ventricular cardiomyopathy associated with arrhythmia-induced cardiomyopathy: A case report [J]. Journal of Peking University (Health Sciences), 2021, 53(5): 1002-1006. |
[14] | Xin-yu WANG,Zhe CUI,Qing-yuan HE,Xiang-ning DENG,Ge GUO,Xin-heng FENG,Jie-li FENG. Assessment of heart’s changes of elite Chinese male weightlifter by speckle tracking echocardiography [J]. Journal of Peking University (Health Sciences), 2021, 53(5): 832-837. |
[15] | GUO Zi-ning, LIANG Zhi-sheng, ZHOU Yi, ZHANG Na, HUANG Jie. Genetic study of cardiovascular disease subtypes defined by International Classification of Diseases [J]. Journal of Peking University (Health Sciences), 2021, 53(3): 453-459. |
|